Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,000 | 234 | 98.4% |
| Education | $67.08 | 3 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,121 | 69 | $0 (2024) |
| PFIZER INC. | $353.96 | 23 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $313.13 | 16 | $0 (2024) |
| Janssen Biotech, Inc. | $300.89 | 17 | $0 (2024) |
| Celgene Corporation | $247.02 | 13 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $206.97 | 13 | $0 (2024) |
| QOL Medical, LLC | $159.00 | 9 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $152.86 | 12 | $0 (2024) |
| GENZYME CORPORATION | $144.49 | 7 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $125.35 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,271 | 69 | ABBVIE INC. ($492.86) |
| 2023 | $1,235 | 71 | ABBVIE INC. ($422.11) |
| 2022 | $499.36 | 26 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($108.54) |
| 2021 | $18.26 | 1 | Daiichi Sankyo Inc. ($18.26) |
| 2020 | $35.20 | 2 | AbbVie Inc. ($23.25) |
| 2019 | $120.52 | 10 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($35.72) |
| 2018 | $313.31 | 19 | Janssen Biotech, Inc. ($102.49) |
| 2017 | $574.81 | 39 | Valeant Pharmaceuticals North America LLC ($114.37) |
All Payment Transactions
237 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $15.07 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/13/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Immunology | ||||||
| 12/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/19/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Immunology | ||||||
| 11/08/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Immunology | ||||||
| 10/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/03/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/27/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $18.29 | General |
| Category: THERAPY FOR CSID | ||||||
| 09/24/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/27/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Immunology | ||||||
| 08/23/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/21/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.73 | General |
| Category: Neuroscience | ||||||
| 08/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/15/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/08/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.93 | General |
| 08/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 659 | 845 | $295,350 | $70,987 |
| 2022 | 12 | 728 | 931 | $319,635 | $76,328 |
| 2021 | 13 | 754 | 921 | $325,447 | $84,970 |
| 2020 | 13 | 599 | 750 | $236,690 | $66,679 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 139 | 139 | $101,206 | $23,985 | 23.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 154 | 323 | $58,140 | $16,549 | 28.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 118 | 132 | $19,140 | $7,462 | 39.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 33 | 33 | $22,275 | $5,682 | 25.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 77 | 79 | $44,017 | $4,482 | 10.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 42 | 42 | $7,550 | $3,072 | 40.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $7,138 | $2,701 | 37.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 26 | 26 | $17,596 | $2,289 | 13.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 11 | 11 | $7,425 | $1,897 | 25.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 19 | $3,800 | $1,542 | 40.6% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 15 | 15 | $7,063 | $1,327 | 18.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 146 | 148 | $107,759 | $25,815 | 24.0% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 154 | 332 | $59,760 | $17,218 | 28.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 140 | 162 | $22,150 | $9,137 | 41.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 92 | 93 | $51,818 | $5,159 | 10.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 23 | 23 | $15,525 | $4,108 | 26.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 52 | 52 | $9,348 | $3,862 | 41.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 34 | 34 | $9,334 | $3,733 | 40.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 13 | 13 | $8,777 | $2,324 | 26.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 25 | $4,975 | $1,938 | 39.0% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 11 | 11 | $7,150 | $1,203 | 16.8% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 13 | 13 | $6,121 | $1,024 | 16.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 25 | 25 | $16,920 | $806.20 | 4.8% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 104 | 106 | $77,179 | $18,853 | 24.4% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2021 | 143 | 283 | $50,940 | $14,270 | 28.0% |
About Dr. Jeevan Pai, MD
Dr. Jeevan Pai, MD is a Gastroenterology healthcare provider based in Cary, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851312870.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeevan Pai, MD has received a total of $4,067 in payments from pharmaceutical and medical device companies, with $1,271 received in 2024. These payments were reported across 237 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($4,000).
As a Medicare-enrolled provider, Pai has provided services to 2,740 Medicare beneficiaries, totaling 3,447 services with total Medicare billing of $298,963. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Cary, NC
- Active Since 07/23/2006
- Last Updated 04/13/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1851312870
Products in Payments
- RINVOQ (Biological) $474.81
- XELJANZ (Drug) $342.74
- DUPIXENT (Biological) $269.84
- STELARA (Biological) $256.75
- ZEPOSIA (Drug) $247.02
- SKYRIZI (Biological) $197.86
- XIFAXAN (Drug) $172.16
- LINZESS (Drug) $151.86
- SUCRAID (Drug) $126.13
- XIFAXANIBSD (Drug) $120.09
- CREON (Drug) $94.02
- ENTYVIO (Biological) $87.47
- CLENPIQ (Drug) $82.53
- Humira (Biological) $82.50
- INJECTAFER (Drug) $77.91
- TRULANCE (Drug) $70.53
- PREPOPIK (Drug) $64.97
- OCALIVA (Drug) $63.98
- HUMIRA (Biological) $61.75
- Cimzia (Drug) $57.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Cary
Subhash Gumber, Md, MD
Gastroenterology — Payments: $134,259
Christopher Mcgowan
Gastroenterology — Payments: $67,271
Dr. Indira Reddy, M.d, M.D
Gastroenterology — Payments: $14,083
Mr. Rajendraprasad Makam, Md, MD
Gastroenterology — Payments: $6,816
Stephen Furs, M.d, M.D
Gastroenterology — Payments: $5,866
Mr. Zachary Spiritos, M.d., M.p.h, M.D., M.P.H
Gastroenterology — Payments: $4,915